SCM
BBNX

Sterling Capital Management’s Beta Bionics BBNX Stock Holding History

Sterling Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79K Sell
378
-122
-24% -$1.8K ﹤0.01% 2828
2025
Q4 		$15.2K Buy
500
+95
+23% +$2.54K ﹤0.01% 2381
2025
Q3 		$8.05K Buy
405
+341
+533% +$5.99K ﹤0.01% 2608
2025
Q2 		$932 Sell
64
-21
-25% -$297 ﹤0.01% 3071
2025
Q1 		$1.04K Buy
+85
New +$1.58K ﹤0.01% 2800

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sterling Capital Management's BBNX Position: Q1 2026 in Review

Sterling Capital Management reduced its Beta Bionics (BBNX) stake by 24% in Q1 2026, selling an estimated $1.8K and leaving 378 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Sterling Capital Management first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.2K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Sterling Capital Management held 378 shares of Beta Bionics worth $3.79K as of Q1 2026.
  • Sterling Capital Management sold 122 Beta Bionics shares in Q1 2026, an estimated $1.8K.
  • Beta Bionics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2828 holding.
  • Sterling Capital Management first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Beta Bionics position peaked at $15.2K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.